Comparison of Nutrition Education Alone or With Acupuncture for Weight Loss in Breast Cancer Patients Post-Chemotherapy
Status: | Active, not recruiting |
---|---|
Conditions: | Breast Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 3/9/2019 |
Start Date: | September 2014 |
End Date: | March 6, 2023 |
Comparison of Weight Loss Among Early Stage Breast Cancer Patients Post Chemotherapy: Nutrition Education in Combination With Weight Loss Acupuncture Vs. Nutrition Education Alone
This study looks at the benefit of adding acupuncture to nutrition education for weight loss
in women with early stage breast cancer post-chemotherapy.
in women with early stage breast cancer post-chemotherapy.
Obesity and weight gain are significant concerns for breast cancer survivors. Given the
adverse consequences of weight gain after diagnosis, continued efforts to identify
appropriate weight management interventions aimed at promoting overall health and long term
survivorship are needed. In this study, the investigators will examine whether adding
acupuncture to a nutrition education program for weight loss could improve short and long
term weight loss among breast cancer survivors post treatment with chemotherapy.
adverse consequences of weight gain after diagnosis, continued efforts to identify
appropriate weight management interventions aimed at promoting overall health and long term
survivorship are needed. In this study, the investigators will examine whether adding
acupuncture to a nutrition education program for weight loss could improve short and long
term weight loss among breast cancer survivors post treatment with chemotherapy.
Inclusion Criteria:
- Woman with a diagnosis of breast cancer, stage I, II, or III
- Age ≥ 18
- ECOG performance status ≤ 1
- Received treatment for breast cancer, and treatment must have been completed at least
2 weeks prior to enrollment in trial, but no longer than 1 year post-treatment.
- BMI ≥ 30
- Adequate bone marrow and organ function as determined by the consenting/enrolling
investigator
- Signed informed consent
- Any receptor status
- Participant is willing and able to comply with the protocol for the duration of the
study including undergoing treatment, scheduled visits, and examinations
Exclusion Criteria:
- Current chemotherapy or radiation therapy. Participants in study may still be
receiving hormone or Herceptin treatment.
- Diagnosis of metastatic breast cancer
- Participation in other diet-based weight loss programs (ie. Patient should not be
currently enrolled in Weight Watchers, Jenny Craig, Nutrisystem, etc.)
- Current use of commercial or natural/herbal weight loss supplements
- Major surgery within 1 month of starting study program and patients must have
recovered from any effects of major surgery
- Other malignancies within the past three years except for adequately treated carcinoma
of the cervix or basal or squamous cell carcinomas of the skin
- Personal history of an eating disorder
- Other serious, uncontrolled medical disorder, non-malignant systemic disease, or
active, uncontrolled infection (including uncontrolled HIV, Hepatitis B or C), or any
psychiatric disorder that prohibits obtaining informed consent
We found this trial at
1
site
1428 Madison Ave
New York, New York 10029
New York, New York 10029
(212) 241-6500
Principal Investigator: Amy Tiersten, MD
Phone: 212-824-7320
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai is...
Click here to add this to my saved trials